TRENTON,
N.J., April 25, 2024 /PRNewswire/ -- BioNJ is
pleased to host its 14th Annual BioPartnering Conference on
Tuesday, May 14, at the Liberty
Science Center in Jersey City.
Sponsored by J.P. Morgan, Johnson &
Johnson and Morgan
Lewis and hosted by Jersey City Economic Development
Corp., the Conference will bring together life sciences
executives, investors, strategics, academic collaborators and
business development professionals for 1-1 partnering, Industry
Connections (office hours with large biopharma companies),
exhibits, company pitch presentations, plenary sessions and lots of
networking -- including a closing networking reception.
The action-packed schedule is designed to create meaningful
opportunities, grow the ecosystem and bolster medical innovation.
Timely plenary sessions will include:
- Industry Overview: Key Trends & Outlook
- BioPartnering: Keys to Success for Biotech and Pharma
Partnerships
- How Biopharma Companies are Using AI to Accelerate
Innovation
- Venture Capital's New Era: Dynamic Shifts and Future
Trends
And, featuring thought leaders, such as:
- Tyler Bryk, Head of
Artificial Intelligence, PTC Therapeutics
- Samuele Butera, President,
U.S. Pulmonary Hypertension & Retina, Johnson & Johnson
& Board Member, BioNJ
- Kim Cato, MBA, Vice
President, Information Technology, Thermo Fisher
Scientific
- Steven M. Cohen, J.D.,
Partner, Morgan Lewis
- Alma DeMetropolis, CFA, CPF,
Managing Director, J.P. Morgan Asset & Wealth
Management
- Jersey City Mayor
Steven Fulop
- David Schwartz, J.D., Partner
& Leader, Corporate & Business Transaction Practice, Morgan
Lewis
- Jim Gunton, MBA, Managing
Partner & Founder, Tech Council Ventures
- Don Hass, J.D., Vice
President, Head, Genetic Medicine Business Development, Regeneron
Pharmaceuticals
- Jenna Hebert, Ph.D., Senior
Venture Associate, RA Capital
- Paul Hoffman, President,
Liberty Science Center
- Sophie Jones, M.D., Managing
Director, J.P. Morgan, Healthcare Investment
Banking
- Alan Leeds, J.D., Partner
& Co-Leader, Global Life Sciences Practice, Morgan Lewis
Partner
- Nancy Ondovik, MBA, Pharm.D.,
Principal, New Company Creation, Johnson & Johnson
- Emilio Ragosa, J.D., Managing
Partner, DLA Piper
- Hal Stern, Vice President
& Chief Information Officer, R&D, Johnson & Johnson
Innovation Medicine
- Phil Tinmouth, MBA, Chief Business Officer, Mammoth
Biosciences
In addition, attendees can schedule 10-minute appointments at
the Industry Connections Desk offering one-on-one time with
BD professionals from large biopharma companies, such as Ferring
Pharmaceuticals, Johnson & Johnson, Merck &
Co., Pfizer, Sanofi and Teva Pharmaceuticals.
"The BioPartnering Conference is the ideal chance to discover
innovative companies for investment portfolios," BioNJ President
and CEO Debbie Hart noted. "We have
more than 90 companies from the life sciences, biotech,
healthcare and digital health sectors presenting new
innovations and technologies. With the One-on-One Partnering System
open, attendees can begin scheduling meetings to explore
collaboration opportunities."
Emerging companies that will be
presenting include:
- 4M Therapeutics
- Accelerated Biosciences
- ACON Pharmaceuticals
- Adiso Therapeutics
- AGelity Biomechanics
- AOA Dx
- ArrePath
- Ascent Bio
- Aspargo Labs
- Avistone Biotechnology
- Benevira
- BioCentriq
- Canget BioTekpharma
- Couragene
- DevaCell
- Enalare Therapeutics
- EpiBone
- FrontAim Biomedicines
- Hanimune Therapeutics
- Iktos
- Illuminare Biotechnologies
- Intrommune Therapeutics
- Jubilant Therapeutics
- KayoThera
- Lactiga US
- Merlin Biotech
- NanomediGene
- NemaGen Discoveries
- Neuropathix
- NuraLogix
- Panavance Therapeutics
- Partex
- PharmaNest
- Regenosine
- Ricovr Healthcare
- Rx Bandz
- Sen-Jam Pharmaceutical
- Sentauri
- Sentrimed
- SFA Therapeutics
- Signum Biosciences
- SkunkWorx Bio
- Soligenix
- Somnia Therapeutics
- Synthis Therapeutics
- Taxis Pharmaceuticals
- TelomEye Pharmaceuticals
- Thread Bioscience
- Torigen
- Vaxine USA
- ViCardia Therapeutics
- Vital Start Health
- Vuja De Sciences
- Xenon Ophthalmics
- Xiconic Pharmaceuticals
- Ziphius
Early stage start-up pitches include:
- 6S Pharma
- Abonics
- Addinex Technologies
- Advent Therapeutics
- Aperture Bio
- Azome Therapeutics
- BioLattice Ophthalmics
- Clinical Trials
- Delphine Diagnostics
- Dimer Health
- Hongyi Therapeutics
- HopeAI
- Inaedis
- Innerstill
- InteguRx Therapeutics
- Kognitic
- KolateAI PharmaTech
- LumaCell
- Materialize Bio
- Mechano Therapeutics
- Monarch Therapeutics
- Neoventech
- NeuroPair
- OLI Technologies
- Orbits Oncology
- Pression
- Prima Innovations
- SciMar ONE
- Synergy Therapeutics
- tenXclinical
- TRIZ Bio Pharma
- Vasowatch
- VITRUVIAE
- Zena Therapeutics
Conference attendees will have the opportunity to meet with a
wide variety of exhibitors showcasing valuable resources,
products and services available to the BioNJ community,
including:
- Advant-Edge
- Amicus Therapeutics
- AscellaHealth
- Ascendia Pharmaceuticals
- BioBridges
- BOME Pharma
- CFGI
- Datasite
- DLA Piper
- Fedsprout
- GenVault
- Grant Thornton
- Jersey City Economic Development Corp.
- Johnson & Johnson
- J.P. Morgan
- Marcum
- Middlesex County
- Morgan Lewis
- NJ Commission on Science, Innovation & Technology
- NJ Israel Commission
- NJ Economic Development Authority
- NJ Health Foundation
- Princeton BioLabs
- Thermo Fisher
- Withum
"We look forward to welcoming BioNJ's preeminent 2024
BioPartnering Conference to the Liberty Science Center and
introducing attendees to SciTech Scity, the 30-acre innovation
campus we are now building that will focus on biomedical science,
home healthcare, planet care and artificial intelligence," said
Paul Hoffman, President and CEO,
Liberty Science Center and SciTech Scity.
Register and find additional information at
BioNJ.org/BioPartnering. Registration is $425 for BioNJ Members and $525 for Future BioNJ Members. Last year's
BioPartnering Conference brought together nearly 600 attendees from
16 states and 16 countries as well as the District of
Columbia.
Media Contact
Randi
Bromberg
Sr. Vice President, Communications and Marketing
O) 609-890-3185
C) 609-955-1067
RBromberg@BioNJ.org
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bionj-announces-lineup-for-biopartnering-conference-302127910.html
SOURCE BioNJ